Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) EBT Margin (2016 - 2025)

Abeona Therapeutics has reported EBT Margin over the past 13 years, most recently at 381.46% for Q4 2025.

  • Quarterly results put EBT Margin at 381.46% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 1075.38% (changed N/A YoY), and the annual figure for FY2025 was 1224.79%, changed.
  • EBT Margin for Q4 2025 was 381.46% at Abeona Therapeutics, down from 31086.25% in the prior quarter.
  • Over the last five years, EBT Margin for ABEO hit a ceiling of 97227.08% in Q4 2021 and a floor of 19285.29% in Q4 2022.
  • Median EBT Margin over the past 4 years was 354.66% (2021), compared with a mean of 10595.56%.
  • Biggest five-year swings in EBT Margin: surged 9775468bps in 2021 and later plummeted -11651238bps in 2022.
  • Abeona Therapeutics' EBT Margin stood at 97227.08% in 2021, then crashed by -120bps to 19285.29% in 2022, then soared by 98bps to 304.49% in 2023, then fell by -25bps to 381.46% in 2025.
  • The last three reported values for EBT Margin were 381.46% (Q4 2025), 31086.25% (Q2 2025), and 304.49% (Q2 2023) per Business Quant data.